Vivotek Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Vivotek hat ein Gesamteigenkapital von NT$3.6B und eine Gesamtverschuldung von NT$425.6M, wodurch sich der Verschuldungsgrad auf 11.7% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen NT$6.1B bzw. NT$2.5B. Vivotek Das EBIT des Unternehmens beträgt NT$330.6M, so dass der Zinsdeckungsgrad -327.7 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von NT$2.1B.

Wichtige Informationen

11.7%

Verhältnis von Schulden zu Eigenkapital

NT$425.58m

Verschuldung

Zinsdeckungsgrad	-327.7x
Bargeld	NT$2.07b
Eigenkapital	NT$3.63b
Gesamtverbindlichkeiten	NT$2.47b
Gesamtvermögen	NT$6.11b

Jüngste Berichte zur Finanzlage

Vivotek (TPE:3454) Has A Pretty Healthy Balance Sheet

Mar 12

We Think Vivotek (TPE:3454) Can Stay On Top Of Its Debt

Dec 08

Recent updates

Vivotek Inc. (TPE:3454) Investors Should Think About This Before Buying It For Its Dividend

Apr 16

Vivotek (TPE:3454) Has A Pretty Healthy Balance Sheet

Mar 12

The Trends At Vivotek (TPE:3454) That You Should Know About

Feb 21

Can Vivotek Inc.'s (TPE:3454) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

Jan 31

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 3454Die kurzfristigen Aktiva des Unternehmens (NT$4.7B) übersteigen seine kurzfristigen Passiva (NT$2.3B).

Langfristige Verbindlichkeiten: 3454Die kurzfristigen Vermögenswerte des Unternehmens (NT$4.7B) übersteigen seine langfristigen Verbindlichkeiten (NT$191.4M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 3454 über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: 3454 Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 13.7% auf 11.7% zurückgegangen.

Schuldendeckung: 3454Die Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (432%).

Zinsdeckung: 3454 mehr Zinsen einnimmt als er zahlt, so dass die Deckung der Zinszahlungen kein Problem darstellt.

Vivotek Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Vivotek (TPE:3454) Has A Pretty Healthy Balance Sheet

We Think Vivotek (TPE:3454) Can Stay On Top Of Its Debt

Recent updates

Vivotek Introduces Ai Entry-Tier 9383-Series Network Camera for All-Around Ai Solution

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Vivotek Inc. Announces Board and Committee Changes

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Vivotek Inc., Annual General Meeting, May 31, 2024

Vivotek Introducing Global Five-Year Warranty, Elevating After-Sales Service to Uphold Sustainable Commitment

Vivotek Inc. Announces Establishment of Risk Management Committee

Vivotek Inc. Announces of Change of Representative by A Juristic Person Director of the Company

New major risk - Revenue and earnings growth

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Share price stability

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Upcoming dividend of NT$5.50 per share at 2.8% yield

Vivotek Inc. Announces Cash Dividend Distribution, Payable on August 31, 2023

Vivotek Inc. Announces Election of New member in Compensation Committee

Vivotek Inc. Approves Cash Dividend for 2022

Investor sentiment improves as stock rises 20%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 18%

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: NT$2.56 (vs NT$0.25 loss in 3Q 2021)

Investor sentiment improved over the past week

VIVOTEK Showcases Next-Generation VMS, VAST Security Station

Investor sentiment improved over the past week

VIVOTEK Launches Highly Anticipated VORTEX AI Surveillance Cloud Service Solution

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: NT$1.57 (vs NT$1.00 in 2Q 2021)

Upcoming dividend of NT$1.40 per share

Vivotek Inc. Approves 2021 Earnings Distribution

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

Vivotek Inc., Annual General Meeting, Jun 17, 2022

Third quarter 2021 earnings released: NT$0.25 loss per share (vs NT$0.76 profit in 3Q 2020)

Upcoming dividend of NT$2.00 per share

Second quarter 2021 earnings released: EPS NT$1.00 (vs NT$0.53 in 2Q 2020)

First quarter 2021 earnings released: EPS NT$0.60 (vs NT$1.02 in 1Q 2020)

Vivotek Inc. (TPE:3454) Investors Should Think About This Before Buying It For Its Dividend

Vivotek (TPE:3454) Has A Pretty Healthy Balance Sheet

Kneron, Inc. signed a share exchange agreement to acquire VATICS INC from Vivotek Inc. (TSEC:3454) for TWD 46.63 million.

Vivotek Inc., Annual General Meeting, Jun 16, 2021

Full year 2020 earnings released: EPS NT$2.90 (vs NT$3.19 in FY 2019)

The Trends At Vivotek (TPE:3454) That You Should Know About

Can Vivotek Inc.'s (TPE:3454) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?

Is Vivotek Inc. (TPE:3454) A Strong Dividend Stock?

Did You Participate In Any Of Vivotek's (TPE:3454) Respectable 60% Return?

New 90-day high: NT$82.30

We Think Vivotek (TPE:3454) Can Stay On Top Of Its Debt

Has Vivotek (TPE:3454) Got What It Takes To Become A Multi-Bagger?

Third quarter 2020 earnings released: EPS NT$0.76

Third quarter earnings released

CyberLink Corp. Collaborates with VIVOTEK to Integrate CyberLink’s FaceMe® Security

New 90-day high - NT$81.40

First half earnings released

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen